Results

Total Results: 149 records

Showing results for "the data in this record is provided by device for informational purposes only seriously".
Search instead for "% the data in this record is provided by denic for informational purposes only. seriously"

141. Acute Treatments for Episodic Migraine: Surveillance Report 3 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/episodic-migraine-surveillance-report-3.pdf
     August 01, 2022 - This is the final surveillance report planned for this systematic review. … Placebo, subgroup analysis by age No study in the original report evaluated this subgroup. … Placebo, subgroup analysis by triptan response No study in the original report evaluated this subgroup … The information in this report is intended to help healthcare decision makers—patients and clinicians … This report is not intended to be a substitute for the application of clinical judgment.

142. Bladder-Cancer-Non-Muscle-Invasive Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/bladder-cancer-non-muscle-invasive_executive.pdf
     October 01, 2015 - Scope of Review and Key Questions This topic was nominated for review by the American Urological Association … We attempted to create two-by-two tables from information provided (sample size, prevalence, sensitivity … The category of moderate risk of bias is broad, and studies with this rating vary in their strengths … accuracy; this situation is common in meta-analyses of diagnostic accuracy.45-47 As noted in the “ … , as research indicates that such methods can be seriously misleading in such situations.49,50 For

143. Atrial-Fibrillation-Ablation Surveillance (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/atrial-fibrillation-ablation_surveillance.pdf
     May 16, 2013 - Introduction The purpose of this mini-report was to apply the methodologies developed by the Ottawa … Further details on the search strategies are provided in the Appendix A of this mini-report. 2.2 … 2] Only one (CER-specific) of the contacted clinical experts has provided response/feedback in the … expert opinion) are provided in Table 1 (Summary Table). … Based on the two assessments (cycles 1-2), this CER is categorized in Low (unchanged from the 1st assessment

144. Antiplatelet-Treatment Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/antiplatelet-treatment_executive.pdf
     September 01, 2013 - For purposes of illustration, we used the counts reported in the studies to compare the treatment effect … of testing for clinical decisionmaking with data stratified by patient characteristics: ancestry in … data for this analysis and CIs were wide (reflecting the low number of homozygous individuals in each … It is unclear whether this delay resulted in harm to patients. … Our confidence in these findings is limited by the relatively small number of studies available for

145. Cad-Women-Treatment Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cad-women-treatment_executive.pdf
     August 01, 2012 - is 7 percent in adults in the United States (8.3% for men, 6.1% for women). … Objectives of This Review Although CAD is the leading cause of death for women in the United States, … This review focused on randomized controlled studies, since this is the strongest study design for … We designed the data abstraction forms for this project to collect the data required to evaluate the … While this was adequate for evaluating the evidence to support the clinical outcomes by treatment strategy

146. Systematic Review on Opioid Treatments for Chronic Pain: Surveillance Report 3 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/opioid-chronic-pain-surveillance-report-3.pdf
     June 01, 2022 - to March 16 2022 Background and Purpose This is the third and final surveillance report for the 2020 … This is the final surveillance update planned for this topic. … In addition, because this is the final surveillance update, meta-analyses for comparisons involving … surveillance reports is provided. … Disclaimers This report is based on research conducted by the Pacific Northwest Evidence-based Practice

147. Systematic Review on Treatments for Acute Pain: Surveillance Report 1 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/main-apps-surv-rept-1-acute-pain.pdf
     May 01, 2022 - Background and Purpose This is the first update for the 2020 report Treatments for Acute Pain: A Systematic … A list of included studies identified for this update is provided in Appendix C and a list of articles … EQ-5D-3L [data not provided]5). … Disclaimers This report is based on research conducted by the Pacific Northwest Evidence-based Practice … This report is not intended to be a substitute for the application of clinical judgment.

148. Systematic Review on Treatments for Acute Pain: Surveillance Report 3 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/main-apps-surv-report-3-acute-pain.pdf
     June 01, 2022 - , 2022 Background and Purpose This is the third and final surveillance report for the 2020 report … This is the final surveillance update planned for this topic. … Because this is the final surveillance update, we updated all of the meta-analyses with new data identified … Disclaimers This report is based on research conducted by the Pacific Northwest Evidence-based Practice … This report is not intended to be a substitute for the application of clinical judgment.

149. CER 217 Management of Infertility Evidence Summary (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-217-infertility-evidence-summary.pdf
     May 01, 2019 - Because of this, the term “subfertility” is preferred by many.1 From a population perspective, couples … for understanding the final strength of evidence, additional explanation is provided. … for understanding the final strength of evidence, additional explanation is provided. … for understanding the final strength of evidence, additional explanation is provided. … for understanding the final strength of evidence, additional explanation is provided.